Expiration date: 09/2026

Action: 

acts as a specific inhibitor of bone resorption carried out by osteoclasts

Composition:

1 tablet contains 91,37 mg of alendronate sodium trihydrate and 53,33 mg of vitamin D3

Excipients: lactose 62,66, cellulose microcrystalline 131,0 mg, silicon dioxide colloidal 0,812 mg, croscarmellose sodium 9,740 mg, magnesium stearate 3,087 mg

Indications:

treatment of osteoporosis in postmenopausal women to prevent the development of hip fractures and compression fractures of the spine and to ensure adequate income of vitamin D

treatment of osteoporosis in men to prevent the occurrence of fractures, as well as to ensure adequate income of vitamin D